An Australian multicentre open label study of pergolide as an adjunct to levodopa in Parkinson's disease
- 1 July 1996
- journal article
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 3 (3) , 234-238
- https://doi.org/10.1016/s0967-5868(96)90056-9
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- A crossover, controlled study comparing pergolide with bromocriptine as an adjunct to levodopa for the treatment of Parkinson's diseaseNeurology, 1995
- A multicenter double‐blind placebo‐controlled trial of pergolide as an adjunct to sinemet® in Parkinson's diseaseMovement Disorders, 1994
- Long‐term study of pergolide in Parkinson's diseaseNeurology, 1985
- Comparison of pergolide and bromocriptine therapy in parkinsonismNeurology, 1983
- Pergolide mesylate and idiopathic Parkinson diseaseNeurology, 1982
- Pergolide in late‐stage Parkinson diseaseAnnals of Neurology, 1982
- Physiologic disposition of pergolideClinical Pharmacology & Therapeutics, 1981
- The pharmacological evaluation of pergolide mesylate as a potential anti-Parkinson agentNeuropharmacology, 1980
- PERGOLIDE AND LISURIDE FOR PARKINSON'S DISEASEThe Lancet, 1979
- Pharmacologic Effects in Man of a Potent, Long-Acting Dopamine Receptor AgonistScience, 1979